Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji
{"title":"作为 MALAT1 RNA 三重螺旋插入因子的 N-融合喹唑啉二酮的无金属合成。","authors":"Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji","doi":"10.1039/D4MD00614C","DOIUrl":null,"url":null,"abstract":"<p >The development of chemical scaffolds that target highly conserved <em>MALAT1</em> RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones <em>via</em> a PIDA-induced C–N coupling methodology to target <em>MALAT1</em>. Interestingly, compound <strong>2z</strong> binds to the UUG pocket of a <em>MALAT1</em> RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. <strong>2z</strong> exhibited cytotoxicity towards <em>MALAT1</em> overexpressing cancer cells (SKOV-3, IC<small><sub>50</sub></small> of 8.0 ± 0.4 μM). These findings demonstrated <strong>2z</strong> as a <em>MALAT1</em> RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand <em>MALAT1</em> activity in disease development pathways.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 1","pages":" 429-434"},"PeriodicalIF":3.5970,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metal-free synthesis of N-fused quinazolino-quinazoline-diones as a MALAT1 RNA triple helix intercalator†\",\"authors\":\"Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji\",\"doi\":\"10.1039/D4MD00614C\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The development of chemical scaffolds that target highly conserved <em>MALAT1</em> RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones <em>via</em> a PIDA-induced C–N coupling methodology to target <em>MALAT1</em>. Interestingly, compound <strong>2z</strong> binds to the UUG pocket of a <em>MALAT1</em> RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. <strong>2z</strong> exhibited cytotoxicity towards <em>MALAT1</em> overexpressing cancer cells (SKOV-3, IC<small><sub>50</sub></small> of 8.0 ± 0.4 μM). These findings demonstrated <strong>2z</strong> as a <em>MALAT1</em> RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand <em>MALAT1</em> activity in disease development pathways.</p>\",\"PeriodicalId\":88,\"journal\":{\"name\":\"MedChemComm\",\"volume\":\" 1\",\"pages\":\" 429-434\"},\"PeriodicalIF\":3.5970,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedChemComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00614c\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00614c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Metal-free synthesis of N-fused quinazolino-quinazoline-diones as a MALAT1 RNA triple helix intercalator†
The development of chemical scaffolds that target highly conserved MALAT1 RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones via a PIDA-induced C–N coupling methodology to target MALAT1. Interestingly, compound 2z binds to the UUG pocket of a MALAT1 RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. 2z exhibited cytotoxicity towards MALAT1 overexpressing cancer cells (SKOV-3, IC50 of 8.0 ± 0.4 μM). These findings demonstrated 2z as a MALAT1 RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand MALAT1 activity in disease development pathways.
期刊介绍:
Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry.
In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.